Skip to main content
. 2006 Jan 31;107(11):4207–4213. doi: 10.1182/blood-2005-10-4222

Table 5.

Two-year FFS according to treatment group among responding patients who are Bcl-6+ and Bcl-6-

Induction and maintenance therapy
Bcl-6+
Bcl-6-
No. 2-y FFS (95% CI) No. 2-y FFS (95% CI) P
R-CHOP + MR 33 82 (67, 96) 5 75 (33, 99) .62
CHOP + MR 25 76 (59, 93) 9 89 (68, 99) .87
R-CHOP + OBS 27 65 (47, 84) 12 82 (58, 99) .12
CHOP + OBS 22 64 (44, 84) 8 13 (1, 35) < .001